Emerging role of interleukin-22 in autoimmune diseases

Chung, 2006, Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes, Cell Research, 16, 902, 10.1038/sj.cr.7310106 Liang, 2006, Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides, Journal of Experimental Medicine, 203, 2271, 10.1084/jem.20061308 Cella, 2009, A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity, Nature, 457, 722, 10.1038/nature07537 Duhen, 2009, Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells, Nature Immunology, 10, 857, 10.1038/ni.1767 Trifari, 2009, Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells, Nature Immunology, 10, 864, 10.1038/ni.1770 Pan, 2009, Decreased serum IL-22 levels in patients with systemic lupus erythematosus, Clinica Chimica Acta, 401, 179, 10.1016/j.cca.2008.11.009 Cheng, 2009, Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus, Annals of the Rheumatic Diseases, 68, 604, 10.1136/ard.2008.097089 Ziesche, 2009, Dexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo, Clinical and Experimental Immunology, 157, 370, 10.1111/j.1365-2249.2009.03969.x McKinley, 2008, TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice, Journal of Immunology, 181, 4089, 10.4049/jimmunol.181.6.4089 Qin, 2011, Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patients, Clinical and Experimental Medicine, 11, 245, 10.1007/s10238-011-0134-9 Yu, 2011, Copy number variations of interleukin-17F, interleukin-21, and interleukin-22 are associated with systemic lupus erythematosus, Arthritis and Rheumatism, 63, 3487, 10.1002/art.30595 Ikeuchi, 2005, Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine, Arthritis and Rheumatism, 52, 1037, 10.1002/art.20965 Geboes, 2009, Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice, Arthritis and Rheumatism, 60, 390, 10.1002/art.24220 da Rocha, 2012, Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity, Journal of Rheumatology, 10.3899/jrheum.111027 Leipe, 2011, Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis, Annals of the Rheumatic Diseases, 70, 1453, 10.1136/ard.2011.152074 Kim, 2012, Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts, Arthritis and Rheumatism, 64, 1015, 10.1002/art.33446 Vandenbroeck, 2012, A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis, Genes and Immunity, 13, 21, 10.1038/gene.2011.44 Beyeen, 2010, IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation, Journal of Immunology, 185, 6883, 10.4049/jimmunol.1001392 Kreymborg, 2007, IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis, Journal of Immunology, 179, 8098, 10.4049/jimmunol.179.12.8098 Lavoie, 2011, Expression of interleukin-22 in Sjogren's syndrome: significant correlation with disease parameters, Scandinavian Journal of Immunology, 74, 377, 10.1111/j.1365-3083.2011.02583.x Ciccia, 2012, Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome, Annals of the Rheumatic Diseases, 71, 295, 10.1136/ard.2011.154013 Wolk, 2009, IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not, Journal of Molecular Medicine (Berlin), 87, 523, 10.1007/s00109-009-0457-0 Zheng, 2007, Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis, Nature, 445, 648, 10.1038/nature05505 Sabat, 2010, IL-10 family of cytokines, Cytokine and Growth Factor Reviews, 21, 315, 10.1016/j.cytogfr.2010.11.001 Dumoutier, 2000, Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9, Journal of Immunology, 164, 1814, 10.4049/jimmunol.164.4.1814 Wolk, 2006, Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells, Cytokine and Growth Factor Reviews, 17, 367, 10.1016/j.cytogfr.2006.09.001 Wolk, 2004, IL-22 increases the innate immunity of tissues, Immunity, 21, 241, 10.1016/j.immuni.2004.07.007 Wolk, 2007, IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease, Journal of Immunology, 178, 5973, 10.4049/jimmunol.178.9.5973 Zhou, 2008, TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function, Nature, 453, 236, 10.1038/nature06878 Veldhoen, 2008, The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins, Nature, 453, 106, 10.1038/nature06881 Zhang, 2011, Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention, Molecular and Cellular Biochemistry, 353, 41, 10.1007/s11010-011-0772-y Eyerich, 2009, Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling, Journal of Clinical Investigation, 119, 3573 Simonian, 2010, gammadelta T cells protect against lung fibrosis via IL-22, Journal of Experimental Medicine, 207, 2239, 10.1084/jem.20100061 Guo, 2010, Interleukin-22 (IL-22) production by pulmonary natural killer cells and the potential role of IL-22 during primary influenza virus infection, Journal of Virology, 84, 7750, 10.1128/JVI.00187-10 Zenewicz, 2011, Recent advances in IL-22 biology, International Immunology, 23, 159, 10.1093/intimm/dxr001 Cupedo, 2009, Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells, Nature Immunology, 10, 66, 10.1038/ni.1668 Takatori, 2009, Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22, Journal of Experimental Medicine, 206, 35, 10.1084/jem.20072713 Sonnenberg, 2010, Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces, Advances in Immunology, 107, 1, 10.1016/B978-0-12-381300-8.00001-0 Xie, 2000, Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R, Journal of Biological Chemistry, 275, 31335, 10.1074/jbc.M005304200 Lejeune, 2002, Interleukin-22 (IL-22) activates the JAK/STAT, ERK JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10, Journal of Biological Chemistry, 277, 33676, 10.1074/jbc.M204204200 Dumoutier, 2009, New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain, Journal of Biological Chemistry, 284, 26377, 10.1074/jbc.M109.007955 Pickert, 2009, STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing, Journal of Experimental Medicine, 206, 1465, 10.1084/jem.20082683 Tagoe, 2012, JAK2 inhibition in murine systemic lupus erythematosus, Immunotherapy, 4, 369, 10.2217/imt.12.20 Jia, 2011, Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-kappaB signaling pathways, PLoS One, 6, e27006, 10.1371/journal.pone.0027006 Jiang, 2009, MOG(35-55) i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways, European Journal of Immunology, 39, 789, 10.1002/eji.200838427 Arumugam, 2012, Involvement of AMPK and MAPK signaling during the progression of experimental autoimmune myocarditis in rats and its blockade using a novel antioxidant, Experimental and Molecular Pathology, 10.1016/j.yexmp.2012.04.012 Noubade, 2011, Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis, Blood, 118, 3290, 10.1182/blood-2011-02-336552 Cope, 2004, Emerging approaches for the therapy of autoimmune and chronic inflammatory disease, Current Opinion in Immunology, 16, 780, 10.1016/j.coi.2004.09.005 Chatenoud, 2006, Immune therapies of autoimmune diseases: are we approaching a real cure?, Current Opinion in Immunology, 18, 710, 10.1016/j.coi.2006.09.004 Kunz, 2009, Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity, Mediators of Inflammation, 2009, 979258, 10.1155/2009/979258 Pan, 2008, Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus, Nature Clinical Practice. Rheumatology, 4, 352, 10.1038/ncprheum0815 Aggarwal, 2003, Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17, Journal of Biological Chemistry, 278, 1910, 10.1074/jbc.M207577200 Garrett-Sinha, 2008, IL-17 and the Th17 lineage in systemic lupus erythematosus, Current Opinion in Rheumatology, 20, 519, 10.1097/BOR.0b013e328304b6b5 van den Berg, 2009, IL-17 as a future therapeutic target for rheumatoid arthritis, Nature Reviews Rheumatology, 5, 549, 10.1038/nrrheum.2009.179 Pollinger, 2012, IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis, Journal of Molecular Medicine (Berlin), 90, 613, 10.1007/s00109-011-0841-4 Mieliauskaite, 2012, Expression of IL-17 IL-23 and their receptors in minor salivary glands of patients with primary Sjogren's syndrome, Clinical & Developmental Immunology, 2012, 187258, 10.1155/2012/187258 Girolomoni, 2012, Psoriasis: rationale for targeting IL-17, British Journal of Dermatology, 10.1111/j.1365-2133.2012.11099.x Semerano, 2012, Anti-cytokine vaccination: a new biotherapy of autoimmunity?, Autoimmunity Reviews, 10.1016/j.autrev.2012.02.003 Ke, 2011, IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis, Journal of Immunology, 187, 2130, 10.4049/jimmunol.1100482 Zenewicz, 2008, IL-22 inflammation: leukin’ through a glass F onion, European Journal of Immunology, 38, 3265, 10.1002/eji.200838655 Schmechel, 2008, Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status, Inflammatory Bowel Diseases, 14, 204, 10.1002/ibd.20315 Lo, 2010, Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy, Journal of Dermatological Science, 58, 225, 10.1016/j.jdermsci.2010.03.018 Ouyang, 2010, Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease, Cytokine and Growth Factor Reviews, 21, 435, 10.1016/j.cytogfr.2010.10.007 Zenewicz, 2007, Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation, Immunity, 27, 647, 10.1016/j.immuni.2007.07.023 Radaeva, 2004, Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation, Hepatology, 39, 1332, 10.1002/hep.20184 Feng, 2012, Interleukin-22 ameliorates cerulein-induced pancreatitis in mice by inhibiting the autophagic pathway, International Journal of Biological Sciences, 8, 249, 10.7150/ijbs.3967 Ma, 2008, IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation, Journal of Clinical Investigation, 118, 597 Van Belle, 2012, IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice, Journal of Immunology, 188, 462, 10.4049/jimmunol.1102224 Marijnissen, 2011, Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation, Arthritis and Rheumatism, 63, 2939, 10.1002/art.30469 Chang, 2006, Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats, Journal of Immunology, 177, 3635, 10.4049/jimmunol.177.6.3635 Pan, 2004, Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3, Cellular & Molecular Immunology, 1, 43